Form 4: NEOGEN CFO Acquires Shares & Options Under 10b5-1 Plan
Insider Transaction Report
NEOGEN's CFO, Richard Bryan Riggsbee, reported the acquisition of 178,855 shares of common stock and 459,713 stock options under a Rule 10b5-1 plan.
Summary
- Richard Bryan Riggsbee, Chief Financial Officer (CFO) of NEOGEN CORP, reported changes in his beneficial ownership of company securities.
- Acquired 178,855 shares of Common Stock at a price of $6.29 per share on November 3, 2025. These shares are Performance Share Units (PSUs) that are expected to vest in total at the end of the three-year anniversary date of the grant.
- Acquired 459,713 derivative securities, specifically a right to buy Common Stock (options), with an exercise price of $6.29 per share on November 3, 2025. These options are scheduled to vest in equal annual installments on each of the first three anniversary dates of the grants.
- The reported transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 7
Explanation: The CFO's acquisition of a substantial number of shares and options, particularly under a 10b5-1 plan, suggests strong confidence in NEOGEN's long-term value and performance, which is generally a positive signal for the market.
Positives
- The CFO's acquisition of a significant number of shares and options indicates strong confidence in NEOGEN's future prospects and long-term value.
- The transactions were executed under a Rule 10b5-1 plan, suggesting a pre-planned and non-discretionary acquisition, which can be viewed positively by investors as it mitigates concerns about opportunistic insider trading.
Future Outlook
The vesting schedules for the acquired options and Performance Share Units (PSUs) indicate a long-term commitment from the CFO, with options vesting over three years and PSUs vesting at the end of a three-year period, aligning management's interests with long-term shareholder value.
Industry Context
This filing represents a standard insider transaction report, common across all publicly traded industries, where executives disclose changes in their beneficial ownership of company securities. Such transactions are often viewed by the market as indicators of management's confidence in the company's future.
Stakeholder Impact
- Shareholders may interpret the CFO's significant acquisition of company stock and options as a positive signal, indicating management's belief in the company's future prospects and potentially bolstering investor confidence.
Next Steps
- The acquired options will vest in equal annual installments on each of the first three anniversary dates of the grant.
- The acquired Performance Share Units (PSUs) will vest in total at the end of the three-year anniversary date of the grant.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Transaction date for the acquisition of 178,855 shares of Common Stock (PSUs) and 459,713 derivative securities (options). |
| 11/03/2025 | First vesting date for options, with subsequent equal annual installments on the first three anniversary dates of the grant. |
| 11/05/2025 | Date the Form 4 was signed by the attorney in fact for the reporting person. |
| 11/03/2028 | Approximate vesting date for the 178,855 PSUs, which vest in total at the end of the three-year anniversary date of the grant. |
Recommendation
holdThe CFO's significant acquisition of company stock and options, executed under a 10b5-1 plan, signals management's belief in the company's future. While a Form 4 alone is not sufficient for a strong 'buy' recommendation, it provides a positive indicator for current shareholders to 'hold' their positions, suggesting potential long-term value and alignment of interests.
Keywords
NEOGEN, NEOG, Form 4, Insider Transaction, CFO, Stock Options, Common Stock, Beneficial Ownership, 10b5-1 Plan, Performance Share Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.